Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2026-02-25 @ 10:05 PM
Study NCT ID:
NCT01886859
Status:
COMPLETED
Last Update Posted:
2022-09-26
First Post:
2013-06-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Recurrent B-Cell Prolymphocytic Leukemia | View |
| None | Recurrent Chronic Lymphocytic Leukemia | View |
| None | Recurrent Small Lymphocytic Lymphoma | View |
| None | Refractory B-Cell Prolymphocytic Leukemia | View |
| None | Refractory Chronic Lymphocytic Leukemia | View |
| None | Refractory Small Lymphocytic Lymphoma | View |
Keywords: